Tech Company Financing Transactions
Global Genes Funding Round
Chan Zuckerberg Initiative participated in a $1.5 million funding round for Global Genes. The funding round closed on 2/18/2025.
Transaction Overview
Company Name
Announced On
2/18/2025
Transaction Type
Debt
Amount
$1,500,000
Round
Undisclosed
Investors
Chan Zuckerberg Initiative (Tania Simoncelli)
Proceeds Purpose
This funding will support the integration of artificial intelligence to enhance data analytics and expand access to a wider range of users including biologists and patient advocates.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
1012 14th Street NW 500
Washington, DC 20005
USA
Washington, DC 20005
USA
Phone
Website
Email Address
Not Recorded
Overview
Global Genes is a 501(c)(3) nonprofit rare disease patient advocacy organization dedicated to providing patients and advocates with a continuum of services to accelerate their path from early support and awareness through research readiness. Using a collaborative approach that involves biopharma, researchers, and advocates with data as a central core, Global Genes also enables research and data collection through the RARE-X research program.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Charlene Rigby
Browse more venture capital transactions:
Prev: 2/18/2025: Employment Hero venture capital transaction
Next: 2/18/2025: Brother's Bond Bourbon venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to document every notable VC transaction. VC investment data records on this site are derived from publicly available VC deal announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs